Cargando…

Novel Immune Cell-Based Therapies to Eradicate High-Risk Acute Myeloid Leukemia

Adverse genetic risk acute myeloid leukemia (AML) includes a wide range of clinical-pathological entities with extremely poor outcomes; thus, novel therapeutic approaches are needed. Promising results achieved by engineered chimeric antigen receptor (CAR) T cells in other blood neoplasms have paved...

Descripción completa

Detalles Bibliográficos
Autores principales:	Limongello, Roberto, Marra, Andrea, Mancusi, Antonella, Bonato, Samanta, Hoxha, Eni, Ruggeri, Loredana, Hui, Susanta, Velardi, Andrea, Pierini, Antonio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8368440/ https://www.ncbi.nlm.nih.gov/pubmed/34413848 http://dx.doi.org/10.3389/fimmu.2021.695051

Ejemplares similares

P813: MALIGNANT PLASMA CELLS PROMOTE EXPANSION OF REGULATORY T CELLS TO CREATE A PROTECTIVE “IMMUNE SHIELD”
por: Limongello, Roberto, et al.
Publicado: (2023)

The Effect of TNF-α on Regulatory T Cell Function in Graft-versus-Host Disease
por: Mancusi, Antonella, et al.
Publicado: (2018)

CD4(+)FOXP3(+) Regulatory T Cell Therapies in HLA Haploidentical Hematopoietic Transplantation
por: Mancusi, Antonella, et al.
Publicado: (2019)

The Evolution of T Cell Depleted Haploidentical Transplantation
por: Aversa, Franco, et al.
Publicado: (2019)

Blinatumomab Redirects Donor Lymphocytes against CD19(+) Acute Lymphoblastic Leukemia without Relevant Bystander Alloreactivity after Haploidentical Hematopoietic Stem Cell Transplantation
por: Mancusi, Antonella, et al.
Publicado: (2023)

Alloreactive Natural Killer Cells for the Treatment of Acute Myeloid Leukemia: From Stem Cell Transplantation to Adoptive Immunotherapy
por: Ruggeri, Loredana, et al.
Publicado: (2015)

Rifaximin use favoured micafungin-resistant Candida spp. infections in recipients of allogeneic hematopoietic cell transplantation
por: Marzuttini, Francesca, et al.
Publicado: (2021)

PB2442: BLINATUMOMAB REDIRECTS DONOR LYMPHOCYTES AGAINST CD19+ ALL WITHOUT INCREASING THE RISK OF BYSTANDER ALLOREACTIVITY AFTER HAPLOIDENTICAL HEMATOPOIETIC CELL TRANSPLANTATION
por: Mancusi, Antonella, et al.
Publicado: (2023)

Editorial: The Immunobiology of HLA-Haploidentical Hematopoietic Cell Transplantation
por: Mancusi, Antonella, et al.
Publicado: (2020)

NK cell defects: implication in acute myeloid leukemia
por: D’Silva, Selma Z., et al.
Publicado: (2023)

Immune Effector Recovery in Chronic Myeloid Leukemia and Treatment-Free Remission
por: Hughes, Amy, et al.
Publicado: (2017)

Notch-Signaling Deregulation Induces Myeloid-Derived Suppressor Cells in T-Cell Acute Lymphoblastic Leukemia
por: Grazioli, Paola, et al.
Publicado: (2022)

Study on the Immune Escape Mechanism of Acute Myeloid Leukemia With DNMT3A Mutation
por: Que, Yimei, et al.
Publicado: (2021)

The cytokine network in acute myeloid leukemia
por: Luciano, Michela, et al.
Publicado: (2022)

Harnessing the Metabolic Vulnerabilities of Leukemia Stem Cells to Eradicate Acute Myeloid Leukemia
por: Kumar, Bijender
Publicado: (2021)

Prognosis and Characterization of Immune Microenvironment in Acute Myeloid Leukemia Through Identification of an Autophagy-Related Signature
por: Fu, Denggang, et al.
Publicado: (2021)

Culture-Expanded Human Invariant Natural Killer T Cells Suppress T-Cell Alloreactivity and Eradicate Leukemia
por: Schmid, Hannes, et al.
Publicado: (2018)

Dendritic Cell-Based Immunotherapy for Myeloid Leukemias
por: Schürch, Christian M., et al.
Publicado: (2013)

Development and Validation of a Novel Prognostic Model for Acute Myeloid Leukemia Based on Immune-Related Genes
por: Li, Ran, et al.
Publicado: (2021)

Comprehensive analysis of the immune pattern of T cell subsets in chronic myeloid leukemia before and after TKI treatment
por: Yao, Danlin, et al.
Publicado: (2023)

One Stone, Two Birds: N6-Methyladenosine RNA Modification in Leukemia Stem Cells and the Tumor Immune Microenvironment in Acute Myeloid Leukemia
por: Ouyang, Xianfeng, et al.
Publicado: (2022)

Thymic Function and T-Cell Receptor Repertoire Diversity: Implications for Patient Response to Checkpoint Blockade Immunotherapy
por: Cardinale, Antonella, et al.
Publicado: (2021)

Tumor Microenvironment in Acute Myeloid Leukemia: Adjusting Niches
por: Menter, Thomas, et al.
Publicado: (2022)

The potential role of the thymus in immunotherapies for acute myeloid leukemia
por: Hino, Christopher, et al.
Publicado: (2023)

Long-Term Outcome After Adoptive Immunotherapy With Natural Killer Cells: Alloreactive NK Cell Dose Still Matters
por: Parisi, Sarah, et al.
Publicado: (2022)

A potential area of use for immune checkpoint inhibitors: Targeting bone marrow microenvironment in acute myeloid leukemia
por: Aru, Başak, et al.
Publicado: (2023)

A novel prognostic classification integrating lipid metabolism and immune co-related genes in acute myeloid leukemia
por: Li, Ding, et al.
Publicado: (2023)

Immunomodulatory Drugs Exert Anti-Leukemia Effects in Acute Myeloid Leukemia by Direct and Immunostimulatory Activities
por: Le Roy, Aude, et al.
Publicado: (2018)

Impact of total marrow/lymphoid irradiation dose to the intestine on graft-versus-host disease in allogeneic hematopoietic stem cell transplantation for hematologic malignancies
por: Saldi, Simonetta, et al.
Publicado: (2022)

Establishment and validation of a carbohydrate metabolism-related gene signature for prognostic model and immune response in acute myeloid leukemia
por: Yang, You, et al.
Publicado: (2022)

Increased NK Cell Maturation in Patients with Acute Myeloid Leukemia
por: Chretien, Anne-Sophie, et al.
Publicado: (2015)

Explainable artificial intelligence for precision medicine in acute myeloid leukemia
por: Gimeno, Marian, et al.
Publicado: (2022)

Bispecific antibody-targeted T-cell therapy for acute myeloid leukemia
por: Kubicka, Ewa, et al.
Publicado: (2022)

Epigenetic targeting to enhance acute myeloid leukemia-directed immunotherapy
por: Rausch, Johanna, et al.
Publicado: (2023)

The More, The Better: “Do the Right Thing” For Natural Killer Immunotherapy in Acute Myeloid Leukemia
por: Parisi, Sarah, et al.
Publicado: (2017)

Plasma Exosomes as Markers of Therapeutic Response in Patients with Acute Myeloid Leukemia
por: Hong, Chang-Sook, et al.
Publicado: (2014)

Targets for chimeric antigen receptor T-cell therapy of acute myeloid leukemia
por: Schorr, Christopher, et al.
Publicado: (2022)

Targeted CD7 CAR T-cells for treatment of T-Lymphocyte leukemia and lymphoma and acute myeloid leukemia: recent advances
por: Liu, Jile, et al.
Publicado: (2023)

Chronic Myeloid Leukemia in Children: Immune Function and Vaccinations
por: Suttorp, Meinolf, et al.
Publicado: (2021)

Case Report: Subtotal Lymphoid and Total Marrow Irradiation as Bridge Therapy to CD19-Directed CAR T Cells in a Chemorefractory DLBCL With Leukemic Involvement
por: Saldi, Simonetta, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5np78rmm644otq8eqqc4hoo660